Biostatistics in clinical R&D has recently emerged as a crucial function in the highly regulated and evidence-based world of Life Sciences. From adaptive protocol design and risk-based analysis, to the final submission, biostatisticians play a critical role in a clinical trial’s success. The rise of precision medicine requires innovative trial design, the ability to democratize data from a variety of sources and compliance with new regulatory requirements. This creates a higher demand for advanced statistical models and skilled resources to deliver timely, cost-optimized and effective support in drug and device development process.

WNS, with over 18 years in Life Sciences, offers biostatistical services to Pharma, Biotech and Medical Device companies and Contract Research Organizations (CROs). We bring together advanced statistical models, deep therapeutic expertise and a team of over 6,000 data analysts and data scientists, including biostatisticians and statistical programmers to support our clients.  With WNS, Life Sciences companies can improve the speed, accuracy and compliance of clinical trials, thus delivering targeted, effective and patient-centric healthcare.